YAFO Received “2019 Best Pharma BD Innovation Award”

[September 11, 2019 Yantai, China] Yafo capital received the “2019 Best Pharma BD Innovation Award” at the 14th China Pharmaceutical and Medtech Business Development Forum, hosted by Luye Pharmaceutical and Weijian Pharmaceutical. The Forum is organized by China Healthcare Business Development (CHBD) and Yafo Capital acts as the Forum’s designated transaction partner. Yafo Capital presented 4 overseas pharma transaction opportunities at the conference.

Sean Jiang, the CEO of YAFO Capital receiving the award

The annual BD Forum is considered to be the most important annual event by the pharmaceutical BD practitioners. The conference invited more than 200 domestic and well-known foreign pharmaceutical companies. Besides, other domestic and overseas industry associations and investment agencies showed up at the conference. About 400 pharma industry leaders joined the conference.

Conference Agenda

Shanghai Yafo Capital (www.yafocapital.com), as a boutique fund management and investment banking firm, specializes in cross-border private equity and M&A transactions. Headquartered in Shanghai, with offices in the US, Israel, Japan, and UK, Yafo Life Science is the healthcare arm under Yafo Capital, with a focus on global pharmaceutical and medical device companies that have a ‘China Angle’. Yafo Life Science is dedicated to bridge the global medical technologies and China market and capital.

For any inquires, please contact:

Ms. Qi Li

Email: info@yafocapital.com